SCHEMBL5673471

SCHEMBL5673471

Cc1ccc(-n2nc(C)c(N=Nc3ccc(C(=O)O)cc3O)c2O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.43
▸ POLB P06746 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ HTT P42858 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ MAPT P10636 4/20 0.38
▸ LMNA P02545 3/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ TP53 P04637 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.37
▸ HPGD P15428 2/20 0.37
▸ SRD5A2 P31213 1/20 0.36
▸ MYC P01106 1/20 0.36
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5673468 1.00 ALDH1A1 (0.43) ALDH1A1POLBMEN1KMT2AKDM4E
SCHEMBL5675277 0.92 HTT (0.43) ALDH1A1POLBMEN1KMT2AKDM4E
SCHEMBL5675192 0.92 HTT (0.43) ALDH1A1POLBMEN1KMT2AKDM4E
SCHEMBL5675278 0.91 MEN1 (0.45) ALDH1A1POLBMEN1KMT2AL3MBTL1
SCHEMBL5675286 0.91 MEN1 (0.45) ALDH1A1POLBMEN1KMT2AL3MBTL1
SCHEMBL5672423 0.90 SMN1; SMN2 (0.40) POLBMEN1KMT2AHTTTDP1
SCHEMBL5672401 0.89 TEAD1 (0.41) POLBMEN1KMT2AKDM4EHTT
SCHEMBL5672403 0.89 TEAD1 (0.41) POLBMEN1KMT2AKDM4EHTT
SCHEMBL5672426 0.89 LMNA (0.42) ALDH1A1POLBMEN1KMT2AL3MBTL1
SCHEMBL5672419 0.89 LMNA (0.42) ALDH1A1POLBMEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1213965-B1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2006-01-18 — — EP claimed
US-6642265-B1 Treating thrombocytopenia, in a mammal, including a human, by administering a hydroxy-1-azobenzene derivative SMITHKLINE BEECHAM CORPORATION 2003-11-04 — — US claimed
EP-1213965-B1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2006-01-18 — — EP disclosed
US-6642265-B1 Treating thrombocytopenia, in a mammal, including a human, by administering a hydroxy-1-azobenzene derivative SMITHKLINE BEECHAM CORPORATION 2003-11-04 — — US disclosed
Send feedback